Log In
BCIQ
Print this Print this
 

IPH52

  Manage Alerts
Collapse Summary General Information
Company Innate Pharma S.A.
DescriptionHuman mAb against ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1; CD39)
Molecular Target Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1) (CD39)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
PartnerOrega Biotech S.A.S.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today